Indiva Limited
NDVAF
$0.021
-$0.0051-19.54%
| Weiss Ratings | NDVAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | NDVAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NDVAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.71 | |||
| Price History | NDVAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.24% | |||
| 30-Day Total Return | -0.24% | |||
| 60-Day Total Return | -0.24% | |||
| 90-Day Total Return | -0.24% | |||
| Year to Date Total Return | -0.24% | |||
| 1-Year Total Return | -67.72% | |||
| 2-Year Total Return | -65.31% | |||
| 3-Year Total Return | -90.28% | |||
| 5-Year Total Return | -86.91% | |||
| 52-Week High % Change | -68.59% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | NDVAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.07 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Jun 12, 2024 | |||
| 52-Week High Price (Date) | Mar 27, 2024 | |||
| Valuation | NDVAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 4.06M | |||
| Enterprise Value | 17.29M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | -64.88% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.14 | |||
| Price/Book (Q) | -4.36 | |||
| Enterprise Value/Revenue (TTM) | 0.66 | |||
| Price | $0.02 | |||
| Enterprise Value/EBITDA (TTM) | -17.29 | |||
| Enterprise Value/EBIT | -14.59 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NDVAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 189.15M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NDVAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 888 649 6686 | |||
| Address | 333 Preston Street Ottawa, ON K1S 5N4 | |||
| Website | www.indiva.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | NDVAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -4.49% | |||
| Profit Margin | -11.84% | |||
| Management Effectiveness | NDVAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -2.80% | |||
| Return on Equity | -- | |||
| Income Statement | NDVAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 27.79M | |||
| Total Revenue (TTM) | 27.79M | |||
| Revenue Per Share | $0.15 | |||
| Gross Profit (TTM) | 8.11M | |||
| EBITDA (TTM) | -1.05M | |||
| EBIT (TTM) | -1.25M | |||
| Net Income (TTM) | -3.29M | |||
| Net Income Avl. to Common (TTM) | -3.29M | |||
| Total Revenue Growth (Q YOY) | -0.57% | |||
| Earnings Growth (Q YOY) | 21.16% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | 38.39% | |||
| Balance Sheet | NDVAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.20M | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 9.85M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -946.30K | |||
| Current Ratio (Q) | 0.703 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 27.93M | |||
| Total Current Liabilities (Q) | 14.01M | |||
| Total Debt (Q) | 16.30M | |||
| Total Liabilities (Q) | 28.87M | |||
| Total Common Equity (Q) | -946.30K | |||
| Cash Flow | NDVAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -309.50K | |||
| Cash from Financing (TTM) | 742.30K | |||
| Net Change in Cash (TTM) | -312.20K | |||
| Levered Free Cash Flow (TTM) | -2.24M | |||
| Cash from Operations (TTM) | -745.10K | |||
